Inhaled antibodies: formulations require specific development to overcome instability due to nebulization
Domains
Human health and pathology
Fichier principal
10.1007-s13346-021-00967-w_Mayor_et_al_2022.pdf (253.76 Ko)
Télécharger le fichier
Origin : Files produced by the author(s)